1
2
3
Jacobs, M S, van Leent, M W J, Tieleman, R G, Jansman, F G A, Cao, Q, Postma, M J, van Hulst, M
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
4
van Hulst, Marinus, Stevanovic, Jelena, Jacobs, Maartje S, Tieleman, Robert G, Kappelhoff, Bregt, Postma, Maarten J
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
5
Vonkeman, Harald E., van de Laar, Mart A. F. J., Brouwers, Jacobus R. B. J., Vermes, Istvan
Veröffentlicht in: Vonkeman , H E , van de Laar , M A F J , Brouwers , J R B J & Vermes , I 2006 , ' Allele variants of the cytochrome P4502C9 genotype in white subjects from the Netherlands with serious gastroduodenal ulcers attributable to the use of NSAIDs ' , Clinical Therapeutics , vol. 28 , no. 10 , pp. 1670-1676 . https://doi.org/10.1016/j.clinthera.2006.10.019;
2006
Veröffentlicht in: Vonkeman , H E , van de Laar , M A F J , Brouwers , J R B J & Vermes , I 2006 , ' Allele variants of the cytochrome P4502C9 genotype in white subjects from the Netherlands with serious gastroduodenal ulcers attributable to the use of NSAIDs ' , Clinical Therapeutics , vol. 28 , no. 10 , pp. 1670-1676 . https://doi.org/10.1016/j.clinthera.2006.10.019;
2006
6
7
8
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
9
Stevanovic, Jelena, Pompen, Marjolein, Le, Hoa H., Rozenbaum, Mark H., Tieleman, Robert G., Postma, Maarten J.
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014